134 related articles for article (PubMed ID: 20227452)
1. A long hangover from party drugs: residual proteomic changes in the hippocampus of rats 8 weeks after γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.
van Nieuwenhuijzen PS; Kashem MA; Matsumoto I; Hunt GE; McGregor IS
Neurochem Int; 2010 Jul; 56(8):871-7. PubMed ID: 20227452
[TBL] [Abstract][Full Text] [Related]
2. Weekly gamma-hydroxybutyrate exposure sensitizes locomotor hyperactivity to low-dose 3,4-methylenedioxymethamphetamine in rats.
van Nieuwenhuijzen PS; Li KM; Hunt GE; McGregor IS
Neuropsychobiology; 2009; 60(3-4):195-203. PubMed ID: 19893336
[TBL] [Abstract][Full Text] [Related]
3. Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
van Nieuwenhuijzen PS; McGregor IS
Drug Alcohol Depend; 2009 Aug; 103(3):137-47. PubMed ID: 19446408
[TBL] [Abstract][Full Text] [Related]
4. Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.
van Nieuwenhuijzen PS; Long LE; Hunt GE; Arnold JC; McGregor IS
Psychopharmacology (Berl); 2010 Dec; 212(4):663-74. PubMed ID: 20730418
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: surface expression of CaMKII and NMDA receptor subunits.
Moyano S; Del Río J; Frechilla D
Pharmacol Biochem Behav; 2005 Sep; 82(1):190-9. PubMed ID: 16154187
[TBL] [Abstract][Full Text] [Related]
6. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
7. A single acute pharmacological dose of γ-hydroxybutyrate modifies multiple gene expression patterns in rat hippocampus and frontal cortex.
Kemmel V; Klein C; Dembélé D; Jost B; Taleb O; Aunis D; Mensah-Nyagan AG; Maitre M
Physiol Genomics; 2010 Apr; 41(2):146-60. PubMed ID: 20103696
[TBL] [Abstract][Full Text] [Related]
8. [A preliminary study on the mechanism of neurotoxicity of MDMA--oxidative stress harm].
Li SX; Sun AM; Wang X; Li J; Peng ZG; Kuang WH; Huang MS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):191-5. PubMed ID: 16608072
[TBL] [Abstract][Full Text] [Related]
9. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
Biezonski DK; Meyer JS
J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
[TBL] [Abstract][Full Text] [Related]
10. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
[TBL] [Abstract][Full Text] [Related]
11. Differential protein expression profiles in the hippocampus of human alcoholics.
Matsuda-Matsumoto H; Iwazaki T; Kashem MA; Harper C; Matsumoto I
Neurochem Int; 2007; 51(6-7):370-6. PubMed ID: 17513015
[TBL] [Abstract][Full Text] [Related]
12. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.
Bull EJ; Porkess V; Rigby M; Hutson PH; Fone KC
J Psychopharmacol; 2006 Mar; 20(2):272-80. PubMed ID: 16510485
[TBL] [Abstract][Full Text] [Related]
13. Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period.
Piper BJ; Meyer JS
Pharmacol Biochem Behav; 2004 Dec; 79(4):723-31. PubMed ID: 15582680
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic configuration of mouse brain induced by adolescent exposure to 3,4-methylenedioxymethamphetamine.
Eun JW; Kwack SJ; Noh JH; Jung KH; Kim JK; Bae HJ; Xie H; Ryu JC; Ahn YM; Min JH; Park WS; Lee JY; Rhee GS; Nam SW
Toxicol Appl Pharmacol; 2009 May; 237(1):91-101. PubMed ID: 19285098
[TBL] [Abstract][Full Text] [Related]
15. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
Yeh SY
Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
[TBL] [Abstract][Full Text] [Related]
16. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats.
Clemens KJ; Cornish JL; Hunt GE; McGregor IS
Drug Alcohol Depend; 2007 Jan; 86(2-3):183-90. PubMed ID: 16884865
[TBL] [Abstract][Full Text] [Related]
17. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
[TBL] [Abstract][Full Text] [Related]
19. The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test.
Sumnall HR; O'Shea E; Marsden CA; Cole JC
Pharmacol Biochem Behav; 2004 Apr; 77(4):805-14. PubMed ID: 15099927
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxicity mechanisms of thioether ecstasy metabolites.
Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
